BiotechTube
Home/Vivace Therapeutics/Sofie Qiao, Ph.D.
SQ

Sofie Qiao, Ph.D.

President and Chief Executive Officer

Vivace Therapeutics

Therapeutic Areas

Oncology

Vivace Therapeutics Pipeline

DrugIndicationPhase
VT3989Refractory pleural and non-pleural mesothelioma; Advanced solid tumors with NF2 mutationsPhase 1/2

Leadership Team at Vivace Therapeutics

NS
Neelesh Sharma, M.D., Ph.D.
Chief Medical Officer
TT
Tracy Tang, Ph.D.
VP of Biology / Head of Biology
AW
Andrei W. Konradi, Ph.D.
Head of Chemistry
AP
Amy Pfeiffer, MBA
Head of Operations
View full Vivace Therapeutics profile